Live feed08:34:38·1137dSECFilingvia QuantisnowNeoleukin Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.NLTX· Neoleukin Therapeutics Inc.Health CareOriginal source
